References
- Ross JC, Hutt DF, Burniston M, et al. Quantitation of (99m)Tc-DPD uptake in patients with transthyretin-related cardiac amyloidosis. Amyloid. 2018;25(3):203–210.
- Wollenweber T, Rettl R, Kretschmer-Chott E, et al. In vivo quantification of myocardial amyloid deposits in patients with suspected transthyretin-related amyloidosis (ATTR). JCM. 2020;9(11):3446.
- Scully PR, Morris E, Patel KP, et al. DPD quantification in cardiac amyloidosis: a novel Imaging biomarker. JACC Cardiovasc Imaging. 2020;13(6):1353–1363.
- Caobelli F, Braun M, Haaf P, et al. Quantitative 99mTc-DPD SPECT/CT in patients with suspected ATTR cardiac amyloidosis: feasibility and correlation with visual scores. J Nucl Cardiol. 2020;27(5):1456–1463.
- Bellevre D, Bailliez A, Delelis F, et al. Quantitation of myocardial (99m)Tc-HMDP uptake with new SPECT/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: Ready for clinical use? J Nucl Cardiol. 2020 [Epub ahead of print]. DOI:10.1007/s12350-020-02274-2.